Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07875595 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immune Biomarkers for Predicting Complications After Liver Transplantation

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This multicenter prospective observational study will evaluate immune biomarkers in adults undergoing liver transplantation. The study aims to describe how immune markers change before and after transplantation and to assess whether these changes are associated with complications such as infections, acute cellular rejection, and viral reactivation during the first year after transplantation. Blood samples will be collected before transplantation, on days 0, 3, and 7 after transplantation, and at months 1, 3, 6, and 12. Biomarkers evaluated will include cytokines, interferons, immunoglobulins, lymphocyte populations, monocyte HLA-DR, neutrophil CD64, functional immune assays, checkpoint molecules, and Torque Teno Virus. Clinical outcomes will be recorded prospectively. Biomarker results will be used for research purposes only and will not modify immunosuppressive treatment or other clinical decisions.
Trial Details
NCT Number NCT07875595
Lead Sponsor Hospital Italiano de Buenos Aires
Collaborators: Austral University, Argentina, Hospital Aleman
Conditions
(from sponsor)		 Liver Transplantation (LT), Immuno-suppression, Biomarkers / Blood, Rejection, Infections
Related terms Infections, Rejection, Psychology
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov